Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Recon Technology (RCON) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Recon Technology (RCON) over the last 17 years, with Q2 2025 value amounting to $13.7 million.

  • Recon Technology's Cash & Equivalents fell 1003.16% to $13.7 million in Q2 2025 from the same period last year, while for Jun 2025 it was $13.7 million, marking a year-over-year decrease of 1003.16%. This contributed to the annual value of $13.8 million for FY2025, which is 880.72% down from last year.
  • Recon Technology's Cash & Equivalents amounted to $13.7 million in Q2 2025, which was down 1003.16% from $19.9 million recorded in Q4 2024.
  • Recon Technology's Cash & Equivalents' 5-year high stood at $54.1 million during Q4 2021, with a 5-year trough of $13.7 million in Q2 2025.
  • In the last 5 years, Recon Technology's Cash & Equivalents had a median value of $19.9 million in 2024 and averaged $31.4 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 114339.24% in 2021, then tumbled by 6914.24% in 2023.
  • Over the past 5 years, Recon Technology's Cash & Equivalents (Quarter) stood at $54.1 million in 2021, then dropped by 15.03% to $45.9 million in 2022, then crashed by 62.65% to $17.2 million in 2023, then grew by 15.98% to $19.9 million in 2024, then crashed by 31.32% to $13.7 million in 2025.
  • Its Cash & Equivalents stands at $13.7 million for Q2 2025, versus $19.9 million for Q4 2024 and $15.2 million for Q2 2024.